Angstrom PharmaceuticalsAbout

About company

Angstrom Pharmaceuticals develops new class of drugs targeting CD44 for the treatment of metastatic diseases and hematological malignancies.

• US
• Unknown
• Unknown
• www.angstrominc.com/
• Not verified company